Viral, cellular and immune aspects of non-suppressible HIV-1 viremia
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://www.nature.com/articles/s41591-023-02688-8.pdf
Reference5 articles.
1. Halvas, E. K. et al. HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus. J. Clin. Investig. 130, 5847–5857 (2020). This study demonstrated that clusters of HIV-1-infected cells can lead to NSV.
2. Podsadecki, T. J., Vrijens, B. C., Tousset, E. P., Rode, R. A. & Hanna, G. J. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia. J. Infect. Dis. 196, 1773–1778 (2007). This study showed that patients with low-level viremia do not always experience virologic failure or develop drug resistance.
3. Vancoillie, L. et al. Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus. Virology 510, 185–193 (2017). This study revealed that in some patients with persistent low-level viremia, there may be no evidence of viral evolution, indicating the absence of active virus replication.
4. White, J. A. et al. Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia. J. Clin. Investig. 133, e165245 (2023). This study showed that proviruses exhibiting 5′-leader sequence deletions can be found in patients with NSV and may lead to the production of envelope-deficient viruses.
5. Palmer, S. et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. USA 105, 3879–3884 (2008). This study indicated that highly sensitive HIV-1 viral load assays can identify very low levels of HIV-1 viremia, even in PWH who appear to have successfully suppressed the virus through ART.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3